Rahsaan Thompson insider trades

Open-market stock purchases and sales by Rahsaan Thompson, Chief Legal & Compliance at Zevra Therapeutics, Inc, from SEC Form 4 filings since May 13, 2020.

Recent trades

DateStockTradeValue
Aug 14, 2026ZVRA Zevra Therapeutics, IncSold$475K
Jun 22, 2026ZVRA Zevra Therapeutics, IncSold$438K
Jun 21, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
May 11, 2026ZVRA Zevra Therapeutics, IncSold$20.3K
Jan 30, 2026ZVRA Zevra Therapeutics, IncSold$36K
Jan 30, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Jan 29, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Jan 29, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—

Companies traded

  • ZVRA Zevra Therapeutics, Inc: 5 sales, last Aug 14, 2026
  • LYEL Lyell Immunopharma, Inc: other filings, last Feb 24, 2023
  • GRTS Gritstone bio, Inc: other filings, last Jan 31, 2022

Get free alerts when Rahsaan Thompson files a new trade →